NetraMark Unveils AI-Discovered Treatment-Responsive Subgroups in A4 Alzheimer’s Trial at ...

NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) , a company developing advanced artificial intelligence solutions for clinical trial optimization and ...
ascopubs.org

Lung cancer enrollment of demographic subgroups in US clinical trial sites.

DAREONTM-9, a phase Ib study of obrixtamig plus topotecan in patients (pts) with advanced small cell lung cancer (SCLC): Interim analysis results. Comprehensive longitudinal immune cell monitoring in ...
National Academies of Sciences%2c Engineering%2c and Medicine

Inclusion of Women in Clinical Trials: Policies for Population Subgroups

Unfortunately, this book can't be printed from the OpenBook. Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.